Pharmaceutical Investing

Cellectar Biosciences Shares CLR 131 Trial Data

Pharmaceutical Investing

Avenue Therapeutics Doses First Patient in Phase 3 Clinical Trial

Pharmaceutical Investing

Sirona Subsidiary Receives Final Loan Tranche

Pharmaceutical Investing

Propanc Biopharma Highlights Therapeutic Potential of PRP

Pharmaceutical Investing

Pelican Therapeutics Announces Manufacturing Agreement with KBI Biopharma

Pharmaceutical Investing

DelMar Pharmaceuticals to Present at AACR Special Conference on Ovarian Cancer

Pharmaceutical Investing

Moleculin Announces FDA Approval of Annamycin IND

Pharmaceutical Investing

CEO Jeffery Bacha Discusses DelMar’s VOL-083 Clinical Trials and the Major Milestones Ahead

Pharmaceutical Investing

ProMetic Obtains FDA Clearance for Phase 2/3 Trials

Pharmaceutical Investing

InMed Shares Update to Biosynthesis Program Development

Pharmaceutical Investing

Corbus Pharmaceuticals to Present New Abstracts Data

Pharmaceutical Investing

Aoxing Announces Delisting and Deregistration of Common Stock

Pharmaceutical Investing

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES